Mostaco-Guidolin LC, Greer AL, Sander B, Wu J, Moghadas SM, Variability in transmissibility of the 2009 H1N1 pandemic in Canadian communities. BMC Research Notes 2011.
Laskowski M, Greer AL, Wu J, Moghadas SM, The impact of demographic variables on disease spread: influenza in remote communities, Scientific Reports 2011.
Mostaco-Guidolin LC, Pizzi NJ, Moghadas SM, A classical approach for estimating the transmissibility of the 2009 H1N1 pandemic, Canadian Applied Mathematics Quarterly 2011.
Mostaco-Guidolin LC, Pizzi NJ, Demko AB, Moghadas SM, A software development framework for agent-based infectious disease modelling, In: Biomedical Engineering, Trends, Researches and Technologies (Book Chapter), IN-TECH 2011.
Bowman CS, Arino J, Moghadas SM, Evaluation of vaccination strategies during pandemic outbreaks. Mathematical Biosciences and Engineering 2011.
Moghadas SM, Emergence of resistance in influenza with compensatory mutations, Mathematical Population Studies, Special Volume in Immunology 2011.
Wessel L, Hua Y, Wu J, Moghadas SM, Public health interventions for epidemics: implications for multiple infection waves. BMC Public Health 2011.
Moghadas SM, Bowman CS, Arino J, Competitive interference between influenza viral strains, Canadian Applied Mathematics Quarterly 2011.
Arino J, Bauch CT, Brauer F, Driedger SM, Greer AL, Moghadas SM, Pizzi NJ, Sander B, Tuite A, van den Driessche P, Watmough J, Wu J, Yan P, Pandemic influenza: modelling and public health perspectives, Mathematical Biosciences and Engineering 2011.
Star L, Moghadas SM, The role of modelling in public health planning and decision making, National Collaborating Centre for Infectious Diseases 2010.
Moghadas SM, Pizzi NJ, Wu J, Tamblyn SE, Fisman DN, Canada in the face of the 2009 H1N1 pandemic, Influenza and Other Respiratory Viruses 2010.
Moghadas SM, Pizzi NJ, Wu J, Yan P, Managing public health crises: the role of models in pandemic preparedness, Influenza and Other Respiratory Viruses 2010.
Hsieh Y-H, Fisman DN, Wu J, On epidemic modeling in real time: An application to the 2009 novel A (H1N1) influenza outbreak in Canada, BMC Research Notes 2010.
Ghosh S, Heffernan J, Influenza pandemic waves under various mitigation strategies with 2009 H1N1 as a case study, PLoS ONE 2010.
Duvvuri VRSK, Moghadas SM, Guo H, Duvvuri B, Heffernan J, Fisman DN, Wu GE, Wu J, Highly conserved cross-reactive CD4+ T-cell HA-epitopes of seasonal and the 2009 pandemic influenza viruses, Influenza and Other Respiratory Viruses 2010.
Greer AL, Tuite A, Fisman DN, Age, influenza pandemics and disease dynamics, Epidemiology and Infection 2010.
Hansen E, Day T, Arino J, Wu J, Moghadas SM, Strategies for use of oseltamivir and zanamivir during pandemic outbreaks, Canadian Journal of Infectious Diseases and Medical Microbiology 2010.
Tuite AR, Greer AL, Whelan M, Winter A-L, Yan P, Wu J, Moghadas SM, Buckeridge D, Pourbohloul B, Fisman DN, Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza, Canadian Medical Association Journal 2010.
Moghadas SM, Day T, Bauch C, Driedger SM, Brauer F, Greer AL, Yan P, Wu J, Pizzi NJ, Fisman DN, Modelling of pandemic influenza: a guide for the perplexed. Canadian Medical Association Journal 2009.
Moghadas SM, Bowman CS, Rost G, Fisman DN, Wu J, Post-exposure prophylaxis during pandemic outbreaks, BMC Medicine 2009.
Tuite A, Fisman DN, Kwong JC, Greer A, Optimal pandemic influenza vaccine allocation strategies for the Canadian population, PLoS Current: Influenza, 2010.
Tuite A, Fisman DN, Kwong JC, Greer A, Seasonal influenza vaccine allocation in the Canadian population during a pandemic, PLoS Current: Influenza, 2010.
Gojovic MZ, Sander B, Fisman DN, Krahn MD, Bauch CT, Modelling mitigation strategies for pandemic (H1N1) 2009, Canadian Medical Association Journal 2009.
Fisman DN, Savage R, Gubbay J, Achonu C, Akwar H, Farrell DJ, Crowcroft NS, Jackson P, Older age and a reduced likelihood of 2009 H1N1 virus infection, New England Journal of Medicine 2009.
Moghadas SM, Prophylaxis of healthcare workers in an influenza pandemic, In: Handbook of Disease Burdens and Quality of Life Measures, Springer−Verlag, 2009.
Arino J, Bowman CS, Moghadas SM, Antiviral resistance during pandemic influenza: implications for stockpiling and drug use, BMC Infectious Diseases 2009.
Sander B, Bauch C, Fisman DN, Fowler R, Kwong JC, McGeer A, Zivkovic-Gojovic M, Krahn M. Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Early evidence from the Canadian experience, PLoS Currents: Influenza, 2009.
Khan K, Memish ZA, Chabbra A, Liauw J, Hu W, Janes DA, Sears J, Arino J, Macdonald M, Calderon F, Raposo P, Heidebrecht C, Wang J, Chan A, Brownstein J, Gardam M, Global public health implications of a mass gathering in Mecca, Saudi Arabia during the midst of an influenza pandemic, Journal of Travel Medicine 2010.
Moghadas SM, Bowman CS, Rost G, Wu J, Population-wide emergence of antiviral resistance during pandemic influenza, PLoS One 2008.